SCHEMBL18616622

SCHEMBL18616622

O=C1CNCCC1c1cccc(Cl)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A3 Q01959 7/20 0.43
SLC6A2 P23975 4/20 0.43
GAA P10253 2/20 0.43
HTT P42858 2/20 0.43
NPSR1 Q6W5P4 1/20 0.43
TP53 P04637 4/20 0.42
MDM2 Q00987 2/20 0.42
LMNA P02545 1/20 0.41
MAPT P10636 2/20 0.39
ALDH1A1 P00352 1/20 0.39
HPGD P15428 1/20 0.39
TSHR P16473 1/20 0.39
DRD2 P14416 1/20 0.39
GABRA1 P14867 1/20 0.39
GABRG2 P18507 1/20 0.39
GABRB3 P28472 1/20 0.39
HTR3E A5X5Y0 1/20 0.38
HTR3B O95264 1/20 0.38
CYP1A2 P05177 1/20 0.38
ADRB1 P08588 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13664708 0.91 LMNA (0.42) SLC6A3SLC6A2GAAHTTNPSR1
SCHEMBL5556432 0.74 LMNA (0.46) SLC6A3SLC6A2GAAHTTNPSR1
SCHEMBL613293 0.73 HTR2C (0.62) SLC6A3SLC6A2GABRA1GABRG2GABRB3
SCHEMBL11231226 0.72 SLC6A4 (0.47) SLC6A3SLC6A2ALDH1A1HTR1ACYP2D6
Hydrochloric Acid SCHEMBL1458622 0.71 HTR2C (0.64) SLC6A3SLC6A2GABRA1GABRG2GABRB3
SCHEMBL13664709 0.71 HTR3A (0.46) SLC6A3SLC6A2SLC6A4HTR3A
SCHEMBL2410760 0.70 HTR3A (0.62) SLC6A3SLC6A2DRD2HTR1ACYP2D6
SCHEMBL18616621 0.70 SLC6A3 (0.42) SLC6A3SLC6A2GAAHTTNPSR1
Hydrochloric Acid SCHEMBL4573020 0.69 HTR3A (0.61) SLC6A3SLC6A2DRD2CYP2D6HTR2C
SCHEMBL13664746 0.69 GABRA1 (0.39) SLC6A3SLC6A2MAPTDRD2GABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017040449-A1 TRIAZOLOPYRIDINE INHIBITORS OF MYELOPEROXIDASE BRISTOL-MYERS SQUIBB COMPANY (US) 2017-03-09 WO disclosed